COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,125,927 | -5.8% | 3,242,227 | +7.5% | 0.00% | 0.0% |
Q2 2023 | $12,874,563 | +269.5% | 3,015,120 | +492.0% | 0.00% | – |
Q1 2023 | $3,483,914 | -38.4% | 509,344 | -28.7% | 0.00% | -100.0% |
Q4 2022 | $5,654,808 | -16.1% | 713,991 | +1.8% | 0.00% | 0.0% |
Q3 2022 | $6,738,000 | +14.4% | 701,028 | -13.8% | 0.00% | 0.0% |
Q2 2022 | $5,888,000 | -22.2% | 813,136 | +38.7% | 0.00% | 0.0% |
Q1 2022 | $7,567,000 | +17.6% | 586,053 | +45.3% | 0.00% | 0.0% |
Q4 2021 | $6,436,000 | -7.0% | 403,298 | -6.4% | 0.00% | 0.0% |
Q3 2021 | $6,922,000 | -19.9% | 430,764 | -31.1% | 0.00% | 0.0% |
Q2 2021 | $8,642,000 | -13.9% | 624,800 | -9.0% | 0.00% | 0.0% |
Q1 2021 | $10,032,000 | +0.2% | 686,651 | +19.2% | 0.00% | -50.0% |
Q4 2020 | $10,015,000 | +119.8% | 576,194 | +131.9% | 0.00% | +100.0% |
Q3 2020 | $4,557,000 | +12.1% | 248,414 | +9.1% | 0.00% | 0.0% |
Q2 2020 | $4,066,000 | +863.5% | 227,613 | +774.2% | 0.00% | – |
Q1 2020 | $422,000 | -90.6% | 26,036 | -89.5% | 0.00% | -100.0% |
Q4 2019 | $4,481,000 | +65.8% | 248,897 | +86.6% | 0.00% | 0.0% |
Q3 2019 | $2,702,000 | +111.3% | 133,362 | +130.4% | 0.00% | – |
Q2 2019 | $1,279,000 | +124.4% | 57,887 | +38.3% | 0.00% | – |
Q1 2019 | $570,000 | -24.3% | 41,849 | -49.7% | 0.00% | – |
Q4 2018 | $753,000 | -54.9% | 83,178 | -17.7% | 0.00% | – |
Q3 2018 | $1,668,000 | -59.5% | 101,117 | -65.7% | 0.00% | -100.0% |
Q2 2018 | $4,122,000 | +91.1% | 294,443 | +50.9% | 0.00% | 0.0% |
Q1 2018 | $2,157,000 | +188.8% | 195,119 | +129.9% | 0.00% | – |
Q4 2017 | $747,000 | -1.2% | 84,880 | +50.0% | 0.00% | – |
Q3 2017 | $756,000 | -13.5% | 56,601 | -7.0% | 0.00% | – |
Q2 2017 | $874,000 | -65.5% | 60,869 | -49.1% | 0.00% | – |
Q1 2017 | $2,530,000 | -69.3% | 119,686 | -59.1% | 0.00% | -100.0% |
Q4 2016 | $8,228,000 | +440.2% | 292,298 | +413.9% | 0.00% | 0.0% |
Q3 2016 | $1,523,000 | +4515.2% | 56,873 | +2843.7% | 0.00% | – |
Q2 2016 | $33,000 | -95.6% | 1,932 | -94.5% | 0.00% | – |
Q1 2016 | $750,000 | +803.6% | 35,297 | +878.6% | 0.00% | – |
Q4 2015 | $83,000 | -73.2% | 3,607 | -76.7% | 0.00% | – |
Q3 2015 | $310,000 | +12.3% | 15,487 | +62.4% | 0.00% | – |
Q2 2015 | $276,000 | +820.0% | 9,535 | +886.0% | 0.00% | – |
Q1 2015 | $30,000 | -96.9% | 967 | -98.4% | 0.00% | – |
Q4 2014 | $959,000 | – | 58,773 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |